White label ELPA - ClinicalTrials.eu

Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis

Recruiting

3 1 1 1
Investigated Diseases:
- C3 glomerulopathy
- Glomerulonephritis membranoproliferative
Investigated Drugs:
- Pegcetacoplan
Study of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)

Recruiting

3 1 1 1
Investigated Diseases:
- Gastric cancer
- Oesophageal adenocarcinoma
Investigated Drugs:
+2
Evaluation of [68Ga]Ga-FAPI-46 PET Imaging for Staging and Detecting Disease Progression in Patients with Transthyretin Cardiac Amyloidosis

Recruiting

2 1 1
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Efficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica

Recruiting

3 1 1
Investigated Drugs:
- Prednisone
- Sarilumab
+3
Phase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies

Recruiting

2 1 1 1
Investigated Drugs:
- Pomalidomide
- Teclistamab
Study of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy

Recruiting

3 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Durvalumab
- Mk-1084
+1
Study of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

Recruiting

4 1 1 1
Investigated Drugs:
- Blinatumomab
- Tocilizumab
+1
Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

Recruiting

3 1 1 1
Investigated Drugs:
Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Mirikizumab
Study of mirikizumab versus azathioprine in newly diagnosed moderate-to-severe Crohn’s disease patients

Recruiting

3 1 1 1
Investigated Drugs:
- Mirikizumab
- Azathioprine

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies